Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes

被引:5
作者
Ren, Jing-Xin [1 ]
Gao, Qian [2 ]
Zhou, Xiao-Chao [3 ]
Chen, Lei [4 ]
Guo, Wei [5 ,6 ]
Feng, Kai-Yan [7 ]
Lu, Lin [8 ]
Huang, Tao [9 ,10 ]
Cai, Yu-Dong [1 ]
机构
[1] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Pharm, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ Sch Med SJTUSM, Ctr Single Cell Om, Sch Publ Hlth, Shanghai 200025, Peoples R China
[4] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
[5] Shanghai Jiao Tong Univ Sch Med SJTUSM, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Biol Sci SIBS, Shanghai 200030, Peoples R China
[7] Guangdong AIB Polytech Coll, Dept Comp Sci, Guangzhou 510507, Peoples R China
[8] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10032 USA
[9] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Biomed Big Data Ctr,CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China
[10] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China
来源
BIOLOGY-BASEL | 2023年 / 12卷 / 07期
关键词
immune cell; COVID-19; severity; machine learning;
D O I
10.3390/biology12070947
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary It is known that COVID-19 causes dynamic changes in the immune system. At different stages of the course of COVID-19, the immune cells may exhibit different patterns, which have not been fully uncovered. In this study, a machine-learning-based method was designed to deeply analyze the scRNA-seq data of three types of immune cells from patients with COVID-19, including B cells, T cells, and myeloid cells. Four levels of COVID-19 severity/outcome were involved for each cell type. As a result, several essential genes were obtained, and some of them could be confirmed to be related to SARS-CoV-2 infection. As COVID-19 develops, dynamic changes occur in the patient's immune system. Changes in molecular levels in different immune cells can reflect the course of COVID-19. This study aims to uncover the molecular characteristics of different immune cell subpopulations at different stages of COVID-19. We designed a machine learning workflow to analyze scRNA-seq data of three immune cell types (B, T, and myeloid cells) in four levels of COVID-19 severity/outcome. The datasets for three cell types included 403,700 B-cell, 634,595 T-cell, and 346,547 myeloid cell samples. Each cell subtype was divided into four groups, control, convalescence, progression mild/moderate, and progression severe/critical, and each immune cell contained 27,943 gene features. A feature analysis procedure was applied to the data of each cell type. Irrelevant features were first excluded according to their relevance to the target variable measured by mutual information. Then, four ranking algorithms (last absolute shrinkage and selection operator, light gradient boosting machine, Monte Carlo feature selection, and max-relevance and min-redundancy) were adopted to analyze the remaining features, resulting in four feature lists. These lists were fed into the incremental feature selection, incorporating three classification algorithms (decision tree, k-nearest neighbor, and random forest) to extract key gene features and construct classifiers with superior performance. The results confirmed that genes such as PFN1, RPS26, and FTH1 played important roles in SARS-CoV-2 infection. These findings provide a useful reference for the understanding of the ongoing effect of COVID-19 development on the immune system.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Extracellular vesicle features are associated with COVID-19 severity
    Caponnetto, Federica
    De Martino, Maria
    Stefanizzi, Daniele
    Del Sal, Riccardo
    Manini, Ivana
    Kharrat, Feras
    D'Aurizio, Federica
    Fabris, Martina
    Visentini, Daniela
    Poz, Donatella
    Sozio, Emanuela
    Tascini, Carlo
    Cesselli, Daniela
    Isola, Miriam
    Beltrami, Antonio Paolo
    Curcio, Francesco
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (24) : 4107 - 4117
  • [22] Identification of COVID-19-Specific Immune Markers Using a Machine Learning Method
    Li, Hao
    Huang, Feiming
    Liao, Huiping
    Li, Zhandong
    Feng, Kaiyan
    Huang, Tao
    Cai, Yu-Dong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [23] Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population
    Chambliss, Allison B.
    Aljehani, Mayada
    Tran, Brian
    Chen, Xingyao
    Elton, Elizabeth
    Garri, Carolina
    Ung, Nolan
    Matasci, Naim
    Gross, Mitchell E.
    PRACTICAL LABORATORY MEDICINE, 2023, 36
  • [24] Immunopathological markers and cell types linked to COVID-19 symptom manifestation
    Song, Ha Won
    Jo, Hye-Yeong
    Kim, Sang Cheol
    Choi, Sun Shim
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [25] On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers
    Vazquez-Jimenez, Aaron
    Avila-Ponce De Leon, Ugo Enrique
    Matadamas-Guzman, Meztli
    Andres Mucino-Olmos, Erick
    Martinez-Lopez, Yoscelina E.
    Escobedo-Tapia, Thelma
    Resendis-Antonio, Osbaldo
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] Association of inflammatory markers with the severity of COVID-19: A meta-analysis
    Zeng, Furong
    Huang, Yuzhao
    Guo, Ying
    Yin, Mingzhu
    Chen, Xiang
    Xiao, Liang
    Deng, Guangtong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 467 - 474
  • [27] Unbiased identification of clinical characteristics predictive of COVID-19 severity
    Akama-Garren, Elliot H.
    Li, Jonathan X.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 22 (01) : 137 - 149
  • [28] Innate Immune Gene Polymorphisms and COVID-19 Prognosis
    Bakaros, Evangelos
    Voulgaridi, Ioanna
    Paliatsa, Vassiliki
    Gatselis, Nikolaos
    Germanidis, Georgios
    Asvestopoulou, Evangelia
    Alexiou, Stamatia
    Botsfari, Elli
    Lygoura, Vasiliki
    Tsachouridou, Olga
    Mimtsoudis, Iordanis
    Tseroni, Maria
    Sarrou, Styliani
    Mouchtouri, Varvara A.
    Dadouli, Katerina
    Kalala, Fani
    Metallidis, Simeon
    Dalekos, George
    Hadjichristodoulou, Christos
    Speletas, Matthaios
    VIRUSES-BASEL, 2023, 15 (09):
  • [29] Phenylalanine and COVID-19: Tracking disease severity markers
    Luporini, Rafael Luis
    Pott-Junior, Henrique
    Leal, Maria Carolina B. Di Medeiros
    Castro, Alex
    Ferreira, Antonio Gilberto
    Cominetti, Marcia Regina
    Anibal, Fernanda de Freitas
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [30] Plasma markers of COVID-19 severity: a pilot study
    Beimdiek, Julia
    Janciauskiene, Sabina
    Wrenger, Sabine
    Volland, Sonja
    Rozy, Adriana
    Fuge, Jan
    Olejnicka, Beata
    Pink, Isabell
    Illig, Thomas
    Popov, Alexander
    Chorostowska, Joanna
    Buettner, Falk F. R.
    Welte, Tobias
    RESPIRATORY RESEARCH, 2022, 23 (01)